News Sentiment

SKIN sentiment intelligence

Beauty Health Co news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 43 Balanced news tone 37 relevant articles
Exchange NASDAQ United States
Sector Consumer Defensive Market context
Industry Household & Personal Products Read-through group
Latest close 0.91 Week of 10 Jul 2026
Weighted tone 43/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

75/100 classification confidence.

Company focus 37

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+25.3% over one week, +39.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Kenvue stock holds steady as the consumer health story builds

Market Reaction

Price moving ahead of tone

65/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 75/100 classification
One-week reaction 25.3% Price confirming higher
Trend fit Trend inactive 39.1% over four weeks
Fair value -59.7% Below fair value
Market Dynamics buy signal Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 21
Negative 13

Relevance

Why the article matched

Direct first
Direct company coverage 37
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
MarketBeat 14
Stock Titan 9
Market source 3
TradingView 2
Ad Hoc News 1
Bloomberg Law News 1
GlobeNewswire 1
TipRanks 1

Event Lens

What the news is about

Classified themes
Market update 16
Earnings 10
Analyst action 6
Regulatory and legal 3
Deals and strategy 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 37
Stock Titan Direct company coverage

SkinHealth (NASDAQ: SKIN) outlines $18M securities class settlement

SkinHealth Systems Inc. (NASDAQ: SKIN) has agreed to a proposed settlement of $18 million for a federal securities class action lawsuit, pending court approval. The company will contribute $3 million from its own cash, with insurers covering the remaining $15 million. This settle

Tone
Neutral 50/100
Event
Regulatory and legal
Published
22 Jun 2026 20:09
Source
Stock Titan
Bloomberg Law News Direct company coverage

Beauty Health Settles Investors’ Spa Device Suit for $18 Million

Beauty Health Co. has agreed to pay $18 million to settle a proposed class action lawsuit. Investors claimed the company misrepresented the success of its Syndeo facial machine for spas. The settlement amount represents about 14% of the estimated maximum damages of $125 million,

Tone
Negative 28/100
Event
Regulatory and legal
Published
18 Jun 2026 16:11
Source
Bloomberg Law News
Stock Titan Direct company coverage

Affiliate files notice to sell Class A shares (NASDAQ: SKIN)

SkinHealth Systems Inc. (NASDAQ: SKIN) has filed a Form 144 notice indicating a proposed sale of Class A common shares by an affiliate. The filing details two restricted stock vesting dates, November 1, 2025, for 114,216 shares and March 17, 2026, for 50,784 shares, with Fidelity

Tone
Neutral 50/100
Event
Market update
Published
20 May 2026 20:41
Source
Stock Titan
TipRanks Direct company coverage

Beauty Health Receives Nasdaq Notice on Bid Price

Beauty Health (SKIN) received a Nasdaq notice on May 8, 2026, due to its stock trading below $1.00 for 30 consecutive business days, violating the exchange's minimum bid price rule. The company has until November 4, 2026, to regain compliance, with possible recourse to measures l

Tone
Negative 19/100
Event
Market update
Published
12 May 2026 21:08
Source
TipRanks
Stock Titan Direct company coverage

SkinHealth Systems (NASDAQ: SKIN) warned over Nasdaq $1 minimum bid price

SkinHealth Systems (NASDAQ: SKIN) received a warning from Nasdaq for failing to meet the $1.00 minimum bid price requirement for 30 consecutive business days. The company has 180 calendar days, until November 4, 2026, to regain compliance by having its stock close at or above $1.

Tone
Negative 18/100
Event
Market update
Published
12 May 2026 21:08
Source
Stock Titan
MarketBeat Direct company coverage

Beauty Health (NASDAQ:SKIN) Announces Earnings Results, Beats Estimates By $0.04 EPS

Beauty Health (NASDAQ:SKIN) reported Q1 EPS of -$0.05, surpassing analyst estimates by $0.04, though revenue of $64.91 million fell short. The company revised its full-year revenue outlook downwards due to weaker device placements but maintained its full-year adjusted EBITDA guid

Tone
Negative 39/100
Event
Earnings
Published
09 May 2026 03:09
Source
MarketBeat
Stock Titan Direct company coverage

FMR LLC boosts disclosure: Beauty Health Co/The (SKIN) 13.4% stake reported

FMR LLC has reported a 13.4% stake in Beauty Health Co/The (SKIN) through a Schedule 13G/A filing, owning 17,183,231 shares of Class A common stock as of March 31, 2026. The filing indicates a passive institutional ownership position, with the Fidelity Growth Company Commingled P

Tone
Neutral 50/100
Event
Deals and strategy
Published
06 May 2026 15:08
Source
Stock Titan
MarketBeat Direct company coverage

The Beauty Health Company (NASDAQ:SKIN) Receives Average Rating of "Hold" from Analysts

The Beauty Health Company (NASDAQ:SKIN) has an average "Hold" rating from eight analysts, with an average 12-month price target of $2.32. Despite reporting quarterly earnings that beat estimates, the company remains unprofitable with negative return on equity. Institutional inves

Tone
Negative 40/100
Event
Analyst action
Published
06 May 2026 07:08
Source
MarketBeat
MarketBeat Direct company coverage

The Beauty Health Company (NASDAQ:SKIN) Given Average Recommendation of "Hold" by Brokerages

Eight research firms have assigned The Beauty Health Company (NASDAQ:SKIN) an average "Hold" rating, with a 12-month average price target of $2.42. Institutional ownership is high at 93.26%, and several major investors have increased their stakes. Despite beating recent revenue a

Tone
Neutral 50/100
Event
Analyst action
Published
11 Apr 2026 06:39
Source
MarketBeat
Stock Titan Direct company coverage

Beauty Health Co (NASDAQ: SKIN) CRO receives 746,681 restricted stock units

The Beauty Health Co (NASDAQ: SKIN) Chief Revenue Officer, Ronald Menezes, was granted 746,681 restricted stock units (RSUs) as part of his compensation. These RSUs will vest in three equal annual installments starting March 20, 2026, contingent on his continued employment. Follo

Tone
Neutral 50/100
Event
Earnings
Published
24 Mar 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Beauty Health Co (NASDAQ: SKIN) CEO granted 2.65M RSUs in new stock award

The CEO of The Beauty Health Co (NASDAQ: SKIN), Pedro Bruno Ferreira Malha, has been granted 2.65 million Restricted Stock Units (RSUs) as part of a new stock award. This equity compensation vests in three equal annual installments beginning March 20, 2026, contingent on continue

Tone
Neutral 50/100
Event
Market update
Published
24 Mar 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Beauty Health Co (NASDAQ: SKIN) grants 746,681 RSUs to CSO and COO

The Beauty Health Co (NASDAQ: SKIN) reported that its CSO and COO, Sheri Lewis, received a grant of 746,681 restricted stock units (RSUs). These RSUs represent equity compensation and will vest in three equal installments over three years, contingent on continued service. Followi

Tone
Neutral 50/100
Event
Market update
Published
24 Mar 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Beauty Health Co (NASDAQ: SKIN) CFO awarded 746,681 restricted stock units

Michael P. Monahan, CFO of Beauty Health Co (NASDAQ: SKIN), has been granted 746,681 restricted stock units (RSUs) as part of a compensation package. These RSUs will vest in three equal annual installments beginning March 20, 2026, contingent on his continued employment. Followin

Tone
Neutral 50/100
Event
Market update
Published
24 Mar 2026 21:10
Source
Stock Titan
MarketBeat Direct company coverage

Mirabella Financial Services LLP Buys 2,734,728 Shares of The Beauty Health Company $SKIN

Mirabella Financial Services LLP increased its stake in The Beauty Health Company (NASDAQ:SKIN) by 21.3%, purchasing over 2.7 million shares in the third quarter, making SKIN its sixth-largest holding. Other institutional investors like Woodline Partners LP and Bank of America Co

Tone
Positive 63/100
Event
Earnings
Published
19 Mar 2026 11:09
Source
MarketBeat
MarketBeat Direct company coverage

Mirabella Financial Services LLP Raises Stock Position in The Beauty Health Company $SKIN

Mirabella Financial Services LLP significantly increased its stake in The Beauty Health Company (NASDAQ:SKIN) by 21.3% in Q3, now owning 12.23% of the company, valued at approximately $31.0 million. Despite this increase, the company remains unprofitable with high leverage and ca

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Mar 2026 11:08
Source
MarketBeat
MarketBeat Direct company coverage

The Beauty Health Company (NASDAQ:SKIN) Receives Consensus Rating of "Reduce" from Brokerages

The Beauty Health Company (NASDAQ:SKIN) has received a consensus "Reduce" rating from eight brokerages, with an average 12-month target price of $2.42. The stock is currently trading around $1.20, with analysts forecasting a negative EPS of approximately -$0.25 for the current ye

Tone
Negative 28/100
Event
Analyst action
Published
17 Mar 2026 06:08
Source
MarketBeat
MarketBeat Direct company coverage

Beauty Health (NASDAQ:SKIN) Price Target Lowered to $1.50 at TD Cowen

TD Cowen has lowered its price target for Beauty Health (NASDAQ:SKIN) from $1.65 to $1.50, while maintaining a "hold" rating, suggesting a potential 14.5% upside from the current share price. The company currently trades around $1.31 with a market cap of $167 million and analysts

Tone
Negative 39/100
Event
Analyst action
Published
16 Mar 2026 14:39
Source
MarketBeat
MarketBeat Direct company coverage

Beauty Health's (SKIN) Hold Rating Reiterated at Canaccord Genuity Group

Canaccord Genuity Group has reiterated a "hold" rating on Beauty Health (SKIN) with a $1.50 price target, suggesting a potential 19.5% upside. This comes after the beauty company beat Q4 revenue and EPS estimates but provided Q1 guidance slightly below consensus and continues to

Tone
Neutral 50/100
Event
Earnings
Published
13 Mar 2026 21:39
Source
MarketBeat
MarketBeat Direct company coverage

Beauty Health (SKIN) Projected to Post Quarterly Earnings on Thursday

Beauty Health (NASDAQ:SKIN) is expected to announce its Q4 2025 earnings after market close on Thursday, March 12, 2026, with analysts projecting an EPS of ($0.07) and revenue of approximately $78.07 million. The company's stock currently holds a "Reduce" rating from analysts wit

Tone
Negative 39/100
Event
Earnings
Published
05 Mar 2026 07:52
Source
MarketBeat
FinancialContent Direct company coverage

The Beauty Health Company - Class A Common Stock (NQ: SKIN)

This article provides recent news headlines and press releases related to The Beauty Health Company (Nasdaq: SKIN). It lists various announcements from 2022 and 2023, including product launches, financial reporting dates, strategic partnerships, and leadership appointments. The c

Tone
Positive 70/100
Event
Market update
Published
28 Feb 2026 06:51
Source
FinancialContent
TradingView Direct company coverage

EBIT per share of Beauty Health Company Class A – GETTEX:V7A0

The article focuses on the EBIT per share for Beauty Health Company Class A, traded under the symbol V7A0 on Gettex. It appears to be a financial data page from TradingView, providing an overview of the company's financial performance metrics. The content indicates that market da

Tone
Neutral 50/100
Event
Market update
Published
27 Feb 2026 05:52
Source
TradingView
MarketBeat Direct company coverage

The Beauty Health Company (NASDAQ:SKIN) Receives Average Rating of "Reduce" from Analysts

The Beauty Health Company (NASDAQ:SKIN) has received an average analyst rating of "Reduce" based on reports from seven research firms, with a consensus 12-month price target of $2.40. The company's stock is currently trading around $1.53, and it recently reported a quarterly EPS

Tone
Negative 29/100
Event
Analyst action
Published
26 Jan 2026 07:30
Source
MarketBeat